Seres Therapeutics Inc Sustainability Reports
Seres Therapeutics Inc. specializes in developing microbiome-based therapies for gastrointestinal diseases, focusing on advancing innovative treatments through microbiome engineering.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US81750R1023
4 reports from 2017 to 2024
Company Profile
Seres Therapeutics Inc
Seres Therapeutics Inc. specializes in developing microbiome-based therapies for gastrointestinal diseases, focusing on advancing innovative treatments through microbiome engineering.
Reports